CpG as a genomic signalling module

A single six-letter DNA sequence—the letters C and G followed by a G and C on the opposite strand—acts as a versatile molecular switch inside human cells, and researchers want to understand exactly how it works. This sequence, called CpG, can exist in three chemical states: unmodified, methylated, or hydroxymethylated. The team’s central idea is that this tiny motif functions as a genomic signalling module—its density and chemical decoration directly shape how DNA is packaged into chromatin, which in turn controls which genes are active. The problem is that the rules of this signalling system remain poorly understood. The researchers will use biochemical, cell-based, and genetic methods to identify common features of CpG islands (clusters of these sequences) and to find proteins that “read” the CpG signal by binding preferentially to its methylated or unmethylated form. This is fundamental science. If successful, it will reveal a core mechanism by which cells interpret their own DNA—a layer of regulation that sits above the genetic code itself. A deeper understanding of CpG signalling could eventually help explain why gene expression goes awry in diseases such as cancer, where DNA methylation patterns are often disrupted, but the project does not promise a direct application. Past discoveries in epigenetics have already led to drugs that reverse abnormal methylation in blood cancers; this work could extend that logic to a broader set of conditions.